Combined Monitoring and Analysis Relieve Staff and Patients Alike
|
By HospiMedica International staff writers Posted on 28 Feb 2013 |
|
Image: The Infinity Gateway Suite is a comprehensive set of applications, developers’ tools, and interfaces that facilitate the exchange of patient information between the Infinity Network and existing hospital systems (Photo courtesy of Dräger Medical).
A technological cooperation is capable of fully automatic capture and analysis of recorded real time electrocardiogram (ECG) data, without additional effort for the clinical staff.
The combined capabilities of the Infinity monitoring system, a product of Dräger Medical (Lübeck, Germany) and the Stroke Risk Analyzer (SRA) clinic system, developed by apoplex medical technologies (Pirmasens, Germany), are intended to assist in the rapid risk analysis ECG data to for paroxysmal atrial fibrillation (pxAF). The Infinity monitoring system gateway records the multichannel ECG and automatically and transfers it as a data packet to the SRAclinic analysis server.
After the analysis of the patient´s ECG data by SRAclinic, the treating physician receives a report within the first therapy hours, which provides information about the individual risk for pxAF and indications regarding acute atrial fibrillation (AF). The report can then help guide in making therapy decisions. Until now, a separate Holter recorder was used to measure long term ECG, which had to be applied to the patient by the clinical staff using electrodes, and needed to be disconnected after recording up to three days of ECG data of. The recorded data were than analyzed following a time delay.
“We are happy having achieved a breakthrough in the detection of paroxysmal atrial fibrillation with our cooperation, and to provide the treating physicians with a unique, fast, easy and clinically validated analysis tool,” said Albert Hirtz, managing director of apoplex medical technologies.
“Unique in our combination is that the ECG data are transferred to SRAclinic without any interaction of the clinical staff,” added Herbert Schmidt, marketing manager of monitoring and IT-systems at Dräger Medical.
AF is often first detected clinically by auscultation by a health care provider; the diagnosis is then confirmed with an ECG. To confirm this diagnosis, patients may wear a portable Holter monitor for continuous ECG recording, since pxAF, episodes occur intermittently, and may only last a few seconds or minutes. pxAF is one of the most frequent causes for stroke, and even after a stroke may sometimes evade detection, and hence is untreated; as a result, the risk for recurrent strokes remains.
Related Links:
Dräger Medical
apoplex medical technologies
The combined capabilities of the Infinity monitoring system, a product of Dräger Medical (Lübeck, Germany) and the Stroke Risk Analyzer (SRA) clinic system, developed by apoplex medical technologies (Pirmasens, Germany), are intended to assist in the rapid risk analysis ECG data to for paroxysmal atrial fibrillation (pxAF). The Infinity monitoring system gateway records the multichannel ECG and automatically and transfers it as a data packet to the SRAclinic analysis server.
After the analysis of the patient´s ECG data by SRAclinic, the treating physician receives a report within the first therapy hours, which provides information about the individual risk for pxAF and indications regarding acute atrial fibrillation (AF). The report can then help guide in making therapy decisions. Until now, a separate Holter recorder was used to measure long term ECG, which had to be applied to the patient by the clinical staff using electrodes, and needed to be disconnected after recording up to three days of ECG data of. The recorded data were than analyzed following a time delay.
“We are happy having achieved a breakthrough in the detection of paroxysmal atrial fibrillation with our cooperation, and to provide the treating physicians with a unique, fast, easy and clinically validated analysis tool,” said Albert Hirtz, managing director of apoplex medical technologies.
“Unique in our combination is that the ECG data are transferred to SRAclinic without any interaction of the clinical staff,” added Herbert Schmidt, marketing manager of monitoring and IT-systems at Dräger Medical.
AF is often first detected clinically by auscultation by a health care provider; the diagnosis is then confirmed with an ECG. To confirm this diagnosis, patients may wear a portable Holter monitor for continuous ECG recording, since pxAF, episodes occur intermittently, and may only last a few seconds or minutes. pxAF is one of the most frequent causes for stroke, and even after a stroke may sometimes evade detection, and hence is untreated; as a result, the risk for recurrent strokes remains.
Related Links:
Dräger Medical
apoplex medical technologies
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hypodermic Syringe
SurTract™ Safety Syringe
Patient Monitoring System
AlarmSense
Latest Critical Care News
- Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
- Bedside CSF Monitor Detects Early Infection in Fluid Drains
- Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
- New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
- AI ECG Tool Detects Cardiac Amyloidosis for Early Screening
- Cuffless Wearable Enables Continuous Blood Pressure Monitoring for Hypertension Care
- AI-Guided System Supports Cardiac Ultrasound Training on Cart-Based Systems
- AI ECG Index Tracks Pubertal Maturation in Children and Adolescents
- Noninvasive AI Tool Enables Pressure-Guided Heart Failure Management
- Regenerative Therapies Aim to Support Recovery After Traumatic Brain Injury
- Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines
- “Intelligent Tattoo” Method Detects Early Melanoma Signals
- Implantable Wireless Light Device Advances Bladder Cancer Treatment
- Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read more
Surgical Techniques
view channel
CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
Thyroid and breast surgeries are often performed in confined anatomical spaces near critical structures, making precise dissection and controlled thermal management essential. As the global disease burden... Read more
3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
Tetralogy of Fallot is one of the most common congenital heart problems and often requires surgery in infancy. Many survivors later develop conduction abnormalities because the cardiac electrical system... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
Point of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read more
Business
view channel
Endologix Adds FDA-Cleared Peripheral Thrombectomy System
Endologix (Santa Rosa, CA, USA) has acquired the Pounce Thrombectomy System from Surmodics, with the transaction closing on May 18, 2026. The FDA-cleared system is indicated for the non-surgical removal... Read more
